4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-019609
CHIEF OPERATING OFFICER sold 6,667 shares at an average $19.79 ($131,951)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2025-07-07 | Sale 10b5-1 | −6,362 | $19.75 | $125,639 | 296,947 | I: show line 1 in the form |
| Patel Anish CHIEF OPERATING OFFICER | 2025-07-07 | Sale 10b5-1 | −305 | $20.69 | $6,312 | 296,642 | I: show line 2 in the form |
| Open-market sales · 6,667 sh · avg $19.79 · $131,951 | |||||||
Loading xslF345X05/form4-07092025_110738.xml…